Cooper Companies | COO - 負債





負債 変化する 日付
Abbott USD 34.05B 20.19B 2026-03
Align Technology USD 116.04M 1.6M 2026-03
AtriCure USD 71.78M 1.6M 2026-03
Bausch Health Companies USD 20.78B 16M 2026-06
Baxter International USD 9.69B 93M 2026-03
Bayer EUR 36.45B 2.93B 2025-12
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Boston Scientific USD 11.03B 407M 2026-03
Cooper Companies USD 2.5B 5.6M 2025-12
Dentsply International USD 2.33B 137M 2026-03
Dexcom USD 1.24B 900K 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Globus Medical USD 115.22M 3.43M 2026-03
Haemonetics USD 1.22B 153K 2026-03
Inogen USD 0 0 2022-06
Insulet USD 948.4M 300K 2026-06
Integra LifeSciences USD 2.04B 6.27M 2026-03
Intuitive Surgical USD 0 0 2025-03
J&J USD 54.99B 7.05B 2026-03
Medtronic USD 27.96B 110M 2026-03
Merit Medical Systems USD 821.56M 9K 2026-03
Novartis USD 47B 14.98B 2026-03
ResMed USD 843.17M 4.55M 2026-03
STAAR Surgical USD 37.29M 1.06M 2026-03
Steris USD 2.09B 33.5M 2026-03
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 132.16M 2026-06
Teleflex USD 2.69B 39.95M 2026-03
Utah Medical Products USD 0 0 2022-03
Zimmer Biomet Holdings USD 7.48B 8M 2026-06